HPV Real World Evidence Virtual Presentation Invitation GP & PHO V3 Dec 2021

Invitation to a Virtual Presentation “HPV Vaccination - New Zealand and International Real World Evidence” Presented by Dr Michelle Van Rensburg- Medical Manager, Seqirus Dates- Tuesday 15th February 2022 or Wednesday 16th February 2022 Time- 7.00pm- 8.00pm RSVP by Email to nzadmin@seqirus.com and we will send you the link details. Please indicate in your response which date you would like to attend.

Seqirus NZ cordially invites you to attend a 1-hour virtual presentation on either Tuesday 15th or Wednesday 16th February 2022.

Michelle will present new Real-World Evidence data on the declining rates of genital warts in New Zealand, and data on the reduction of cervical intraepithelial neoplasia (CIN) and colposcopy referrals across Auckland, Waikato and Christchurch.

Michelle will also present international data from Swedish and UK studies showing the relationship between early vaccination and reduction in risk of cervical cancer.

A certificate of attendance will be provided on request.

If you would like more information, please contact your local Seqirus Representative: Paul Kelly- Central, West and North Shore Auckland and Northland Tel. 021 383 723 Email. Paul.kelly@seqirus.com Praveen Nalam- South Auckland and Eastern Suburbs Tel. 027 482 1305 Email. Praveen.Nalam@seqirus.com Brian Booth- Central North Island Tel. 027 230 6011 Email. brian.booth@seqirus.com Simonne Findlater- South Island and Wellington Tel. 027 485 7812 Email. simonne.findlater@seqirus.com

Biography- Dr Michelle van Rensburg As Medical Manager at Seqirus (NZ) Ltd, Michelle works across a variety of therapeutic portfolios including HPV, influenza and travel vaccines. After completing a doctorate in Medicinal Chemistry focusing on the development of new anti-cancer and neuroprotective drug candidates, Michelle continued research in the development of anti-cancer candidates whilst holding PostDoctoral Fellowships at the University of Auckland. With a strong clinical foundation and knowledge of drug design and development, Michelle now enjoys working on the other end of drug development, ensuring patients and healthcare professionals are equipped with the information they need to be able to make informed decisions regarding their health.

As Seqirus abides by the Medicines NZ Code of Practice, only healthcare professionals registered to attend may join this event.

If you do not wish to receive further information about (please tick): Seqirus educational events Seqirus products and services, please email nzadmin@seqirus.com

Privacy Notice: The information requested on this form will be used by Seqirus NZ Ltd in connection with the educational event described in this invitation. If this information is not provided it may not be possible to perform the function or service in relation to which we requested the information.

We may disclose personal information to third parties including related companies, regulatory authorities and contractors engaged to provide services to Seqirus. Some of these entities may be located outside of New Zealand, in countries including (but not limited to) the United States, Switzerland and countries within the European Union. To the extent that you may be entitled to do so under the Privacy Act and any other applicable laws, you may request access to, or correction of, your personal information held by Seqirus by contacting our Privacy Officer on email: privacy@Seqirus.com.au, or at Seqirus (NZ) Ltd, P O Box 62 590. Greenlane Auckland 1546; or freephone 0800 502 757. Further information regarding Seqirus’s handling of personal information, including how you can seek access to or correction of personal information held about you by Seqirus and how you can make a complaint about our handling of personal information, is set out in our Privacy Policy available at www.Seqirus.com.au/privacy.